Directory of funded grants

Filter by

534 results found

Effects of Cannabis on Stress Response: A Double-Blind Randomized Placebo-Controlled fMRI Study

  • Program Type

    Capacity building grants

  • Area of research

    Mental Health

  • Disease Area

    Mental illness

  • Competition

    Canadian Consortium for the Investigation of Cannabinoids (CCIC) Neuroscience Fellowship in Cannabis and Cannabinoid Research

  • Province

    British Columbia

  • Start Date

    2023

  • Total Grant Amount

    $12,000

  • Health Canada Contribution

    $6,000

Project Overview

Nearly 50% of Canadians have used cannabis at least once in their lifetime. The vast majority of cannabis users report using cannabis to reduce stress. While there is some evidence to suggest that cannabis may impact the body’s stress regulation systems via the endocannabinoid system, there remains limited experimental evidence…

Mitochondrial dysfunction and vulnerability to oxidative stress in induced dopaminergic neurons derived from idiopathic Parkinson’s disease patients

  • Program Type

    Capacity building grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Parkinson's

  • Competition

    Brain Canada Next Gen Award in Parkinson’s Disease Research

  • Province

    Québec

  • Start Date

    2023

  • Total Grant Amount

    $12,000

  • Health Canada Contribution

    $6,000

Project Overview

Parkinson’s Disease (PD) is an age-associated movement disorders, mainly caused by the death of dopamine cells in the brain. Over 90% of PD cases are idiopathic (iPD), that is, of unknown etiology. What causes dopamine cell death is not fully understood, but evidence suggests that mitochondria, the powerhouse of the…

Stability-Based Biomarker Development to Identify Pathological Brain Areas Responsible for Freezing of Gait in Parkinson’s Disease

  • Program Type

    Capacity building grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Parkinson's

  • Competition

    Brain Canada Next Gen Award in Parkinson’s Disease Research

  • Province

    Ontario

  • Start Date

    2023

  • Total Grant Amount

    $12,000

  • Health Canada Contribution

    $6,000

Project Overview

Brain stimulation involves using electrical or magnetic pulses to treat medical disorders like Parkinson's by sending controlled pulses to the brain in order to manage patient symptoms. Even though brain stimulation has been quite successful and is widely accepted, there are still important things that remain unknown. One of the…

Intraoperative Identification of Residual Brain Tumour Using a Novel High-Resolution Ultrasound Endoscope and Integrated Neuronavigation System

  • Program Type

    Capacity building grants

  • Area of research

    Cancer

  • Disease Area

    Brain Cancer

  • Competition

    Henry and Berenice Kaufmann Foundation Trainee Award in Brain Cancer Research

  • Province

    Nova Scotia

  • Start Date

    2023

  • Total Grant Amount

    $12,000

  • Health Canada Contribution

    $6,000

Project Overview

20,800 North Americans die from brain cancer each year. This project aims to improve patient outcomes by helping surgeons remove tumours with higher accuracy and less damage to healthy brain. When removing brain tumours, surgeons guide the operation visually and with a microscope. This can be challenging as the path…

Mechanisms of response and resistance to Olaparib and Durvalumab in treatment of glioblastomas and IDH-mutated astrocytomas

  • Program Type

    Capacity building grants

  • Area of research

    Cancer

  • Disease Area

    Brain Cancer

  • Competition

    Henry and Berenice Kaufmann Foundation Trainee Award in Brain Cancer Research

  • Province

    Ontario

  • Start Date

    2023

  • Total Grant Amount

    $10,000

  • Health Canada Contribution

    $5,000

Project Overview

Glioblastoma multiforme and high grade astrocytomas are aggressive brain tumors that are difficult to treat. These tumors have genetic changes that affect their ability to repair DNA. Recent research has discovered that a combination of two drugs, Olaparib and Durvalumab, could be effective in treating these tumors. Olaparib blocks a…